Business StandardCenter·
Mankind Pharma signs China pact to market insulin analogues in India
Firm eyes more partnerships with Chinese pharmaceutical companies to expand its in-licensed drug pipeline as it seeks a larger presence in injectable diabetes therapies
Read at Business Standard →



